Venous access devices utilized in association with intensive cancer chemotherapy.
Consistent and reliable venous access is a major component of the management of patients with cancer undergoing chemotherapy. Venous access devices such as the long-term right atrial catheter and the subcutaneous port have become a major aspect of the supportive care of such individuals, with resultant advantages which have improved their quality of life. Yet, the occurrence of infectious and non-infectious complications restricts the usefulness of these devices and warrants a standardized approach to device placement, patient education and the management of such complications. Infectious complications, including exit site and tunnel infections, as well as bacteremias requiring catheter removal occur at a rate of approximately two episodes for every 1000 catheter days, while non-infectious complications occur more frequently. Uniform patient education and catheter care, as well as placement by a single consistent surgeon will decrease the frequency of complications, improve the longevity and function of these venous access devices, while minimizing the associated morbidity.
Newman
K A
KA
University of Maryland Cancer Center, University of Maryland Hospital and Medical Center, Baltimore, MD 21201.
Reed
W P
WP
Bustamante
C I
CI
Schimpff
S C
SC
Wade
J C
JC
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006328:Cardiac Catheterization / Q000009:adverse effects; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D004866:Equipment Contamination; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents